These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37917623)

  • 21. Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant.
    Shi W; Kou Y; Jiang H; Gao F; Kong W; Su W; Xu F; Jiang C
    Immunol Lett; 2018 Jun; 198():26-32. PubMed ID: 29601940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bordetella pertussis from functional genomics to intranasal vaccination.
    Locht C; Antoine R; Raze D; Mielcarek N; Hot D; Lemoine Y; Mascart F
    Int J Med Microbiol; 2004 Apr; 293(7-8):583-8. PubMed ID: 15149035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
    Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
    Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outer membrane vesicles obtained from Bordetella pertussis Tohama expressing the lipid A deacylase PagL as a novel acellular vaccine candidate.
    Asensio CJ; Gaillard ME; Moreno G; Bottero D; Zurita E; Rumbo M; van der Ley P; van der Ark A; Hozbor D
    Vaccine; 2011 Feb; 29(8):1649-56. PubMed ID: 21211579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
    Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
    Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.
    Skerry CM; Cassidy JP; English K; Feunou-Feunou P; Locht C; Mahon BP
    Clin Vaccine Immunol; 2009 Sep; 16(9):1344-51. PubMed ID: 19625486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bactericidal monoclonal antibody specific for the lipooligosaccharide of Bordetella pertussis reduces colonization of the respiratory tract of mice after aerosol infection with B. pertussis.
    Mountzouros KT; Kimura A; Cowell JL
    Infect Immun; 1992 Dec; 60(12):5316-8. PubMed ID: 1452367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine.
    Solans L; Debrie AS; Borkner L; Aguiló N; Thiriard A; Coutte L; Uranga S; Trottein F; Martín C; Mills KHG; Locht C
    Mucosal Immunol; 2018 Nov; 11(6):1753-1762. PubMed ID: 30115992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serospecific protection of mice against intranasal infection with Bordetella pertussis.
    Robinson A; Gorringe AR; Funnell SG; Fernandez M
    Vaccine; 1989 Aug; 7(4):321-4. PubMed ID: 2573215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mouse intranasal challenge model for potency testing of whole-cell pertussis vaccines.
    Queenan AM; Fernandez J; Shang W; Wiertsema S; van den Dobbelsteen GP; Poolman J
    Expert Rev Vaccines; 2014 Oct; 13(10):1265-70. PubMed ID: 25029905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental respiratory infection with Bordetella pertussis in mice: comparison of two methods.
    Halperin SA; Heifetz SA; Kasina A
    Clin Invest Med; 1988 Aug; 11(4):297-303. PubMed ID: 3168352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective activities in mice of monoclonal antibodies against pertussis toxin.
    Sato H; Sato Y
    Infect Immun; 1990 Oct; 58(10):3369-74. PubMed ID: 1698179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of experimental whole-cell pertussis vaccines in murine model.
    Polak M; Zawadka M; Mosiej E; Rabczenko D; Augustynowicz E; Lutyńska A
    Med Dosw Mikrobiol; 2014; 66(2):79-87. PubMed ID: 25369654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuated Bordetella pertussis BPZE1 protects against allergic airway inflammation and contact dermatitis in mouse models.
    Li R; Cheng C; Chong SZ; Lim AR; Goh YF; Locht C; Kemeny DM; Angeli V; Wong WS; Alonso S
    Allergy; 2012 Oct; 67(10):1250-8. PubMed ID: 22909095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1.
    Feunou PF; Kammoun H; Debrie AS; Mielcarek N; Locht C
    Vaccine; 2010 Oct; 28(43):7047-53. PubMed ID: 20708998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.
    Sukumar N; Sloan GP; Conover MS; Love CF; Mattoo S; Kock ND; Deora R
    Infect Immun; 2010 May; 78(5):2008-16. PubMed ID: 20176797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection.
    Denoël P; Poolman J; Carletti G; Veitch K
    Vaccine; 2002 Jun; 20(19-20):2551-5. PubMed ID: 12057612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal inoculation with
    Naninck T; Contreras V; Coutte L; Langlois S; Hébert-Ribon A; Pelletier M; Reveneau N; Locht C; Chapon C; Le Grand R
    Curr Res Microb Sci; 2021 Dec; 2():100072. PubMed ID: 34841362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.
    Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C
    PLoS Pathog; 2006 Jul; 2(7):e65. PubMed ID: 16839199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.